beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor (Q34099593)

31 July 2017

beta-Synuclein inhibits alpha-synuclein aggregation: a possible role as an anti-parkinsonian factor (English)

1 reference

31 July 2017

1 reference

1 reference

5

Masliah E

1 reference

31 July 2017

Hashimoto M

1

1 reference

31 July 2017

Rockenstein E

series ordinal

2

1 reference

31 July 2017

Mante M

series ordinal

3

1 reference

31 July 2017

Mallory M

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

31 July 2017

1 reference

31 July 2017

32

1 reference

31 July 2017

213-223

1 reference

31 July 2017

2

1 reference

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Review: formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

A Drosophila model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Alpha-synuclein in Lewy body disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

alpha-synuclein promotes mitochondrial deficit and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Properties of NACP/alpha-synuclein and its role in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

alpha-Synuclein forms a complex with transcription factor Elk-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Residues in the synuclein consensus motif of the alpha-synuclein fragment, NAC, participate in transglutaminase-catalysed cross-linking to Alzheimer-disease amyloid beta A4 peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

alpha-Synuclein membrane interactions and lipid specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Amyloid diseases: abnormal protein aggregation in neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Intracellular polymerization. Disease severity and therapeutic predictions

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35).

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Copper(II)-induced self-oligomerization of alpha-synuclein.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Synoretin--A new protein belonging to the synuclein family

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2801%2900462-7

7 January 2021

10.1016/S0896-6273(01)00462-7

Identifiers

DOI

1 reference

31 July 2017

1 reference